Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial

Japanese Eculizumab Trial for GBS (JET-GBS) Study Group

Research output: Contribution to journalArticlepeer-review

63 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences